AI-enabled capabilities reduce manual document authoring by up to 70–80%, accelerate aggregate report preparation, and transform regulated document management
BOSTON, Massachusetts, USA – August 3, 2026 – ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced its enhanced NavaX-powered Advanced Compliance Docs solution, bringing embedded AI across the creation, management, and maintenance of regulated pharmacovigilance documentation to help organizations accelerate submissions, reduce manual effort, strengthen compliance, and improve inspection readiness.
As regulatory requirements become more complex, pharmacovigilance and medical writing teams are under increasing pressure to prepare high-quality aggregate reports while maintaining compliance and meeting evolving submission timelines. NavaX-powered Advanced Compliance Docs replaces fragmented, manual document preparation with intelligent automation that orchestrates document authoring, review, approval, and submission.
The new capabilities enable life sciences organizations to:
- Reduce manual document authoring effort by up to 70–80%
- Accelerate preparation of key aggregate reports, including PBRERs, DSURs and PADERs
- Improve document consistency through AI-assisted content generation
- Maintain complete traceability and auditability across every document lifecycle
- Strengthen inspection readiness with centralized document management and intelligent workflows
Embedded throughout Advanced Compliance Docs, NavaX automates and augments critical workflows, including:
- AI-Assisted Report Authoring: Accelerates document authoring by generating draft content from connected data sources. Reduces manual effort while supporting human review and verification.
- Intelligent Data Collection & Auto-Population: Automatically gathers, synthesizes, and contextualizes information from multiple data sources to populate report templates and reduces manual effort.
- Report Reuse & Content Refresh: Leverages previously authored reports to carry forward relevant content, preserve report structure and formatting, and intelligently update sections with the latest available information, enabling faster and more consistent report creation.
- Collaborative Review & Approval: Supports secure multi-author collaboration with configurable review workflows, version control, electronic approvals, and complete audit trails.
- Operational Dashboards & Workflow Intelligence: Provides real-time visibility into document status, reporting timelines, submission readiness, and operational performance.
“Medical writing and pharmacovigilance teams need more than AI that automates individual document tasks — they need AI that transforms how regulated content is created and managed,” said Lucinda Smith, Chief Safety Product Officer at ArisGlobal. “With NavaX-powered Advanced Compliance Docs, we’re embedding trusted AI across the entire document lifecycle—from data collection and authoring through review, approval, and submission. By reducing manual effort while keeping scientific experts firmly in control, organizations can improve compliance, accelerate submissions, and produce higher-quality regulatory documents at scale.”
In addition to AI-powered Medical Writing capabilities for aggregate reports, Advanced Compliance Docs also supports other key pharmacovigilance compliance processes, including:
- Pharmacovigilance Agreement (PVA) Management: Simplifies the creation, review, approval, and maintenance of PVAs using standardized templates and intelligent workflow automation.
- Pharmacovigilance System Master File (PSMF) Management: Maintains inspection-ready PSMFs through centralized content management, automated change tracking, and lifecycle controls.
The launch further expands ArisGlobal’s NavaX AI platform, which delivers embedded AI across the R&D ecosystem. By combining domain-specific AI with connected workflows on the LifeSphere platform, ArisGlobal continues to help life sciences organizations improve productivity, reduce complexity, and accelerate better decisions across the product lifecycle.
